{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:42:46Z","timestamp":1789040566878,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Treatment of acute bacterial meningitis in children with bactericidal antibiotics causes cell wall lysis and a surge in inflammatory cascade, which in turn contributes to neuronal damage and morbidity. Pretreatment with a nonbacteriolytic antibiotic, such as rifampin, has been shown to attenuate the inflammatory response in experimental models of bacterial meningitis. In a pilot study, in children with bacterial meningitis, we have studied markers of inflammatory response and neuronal damage in 2 groups of children with bacterial meningitis; one group received rifampin pretreatment with ceftriaxone and the other group received ceftriaxone alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>Forty children with bacterial meningitis, who were 3 months to 12 years of age, were randomly assigned to receive either a single dose rifampin (20 mg\/kg) 30 minutes before ceftriaxone or ceftriaxone alone was given. The primary outcome variables were cerebrospinal fluid (CSF) concentrations of tumor necrosis factor alpha (TNF\u03b1), S100B and neuron-specific enolase on day 1 and day 5, and secondary outcome variables were the values of TNF\u03b1 and interleukin 6 in serum on day 1 and day 5; hearing and neurologic sequelae at 3 months after recovery from the illness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Children in rifampin pretreatment group had significantly lower CSF TNF\u03b1 concentrations [median (interquartile range [IQR]): 15.5 (7.2\u201322.0) vs. 53.0 (9.0\u201387.5) pg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.019] and S100B [median (IQR): 145.0 (54.7\u2013450.0) vs. 447.5 (221.0\u2013804.6) pg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.033] on day 1 and S100B [median (IQR): 109.7 (64.0\u2013287.0) vs. 322 (106.7\u2013578.0) pg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.048] and neuron-specific enolase [median (IQR): 8.6 (5\u201314.75) vs. 18.2 (7.0\u201328.75) ng\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.035] on day 5 when compared with ceftriaxone alone group. The rifampin-treated group also had reduced morbidity and neurologic sequelae; however, these were not statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Pretreatment with single dose rifampin 30 minutes before ceftriaxone administration reduced the CSF concentrations of markers of inflammation and neuronal damage in children with bacterial meningitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001513","type":"journal-article","created":{"date-parts":[[2016,12,25]],"date-time":"2016-12-25T16:59:02Z","timestamp":1482685142000},"page":"556-559","source":"Crossref","is-referenced-by-count":11,"title":["Role of Rifampin in Reducing Inflammation and Neuronal Damage in Childhood Bacterial Meningitis"],"prefix":"10.1097","volume":"36","author":[{"given":"Lipi","family":"Uppal","sequence":"first","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunit","family":"Singhi","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Singhi","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-7-47","article-title":"Sequelae due to bacterial meningitis among African children: a systematic literature review.","volume":"7","author":"Ramakrishnan","year":"2009","journal-title":"BMC Med"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(11)60580-1","article-title":"5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study.","volume":"377","author":"Molyneux","year":"2011","journal-title":"Lancet"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12098-007-0062-6","article-title":"Predictors of long term neurological outcome in bacterial meningitis.","volume":"74","author":"Singhi","year":"2007","journal-title":"Indian J Pediatr"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1471-4159.2006.04085.x","article-title":"Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.","volume":"99","author":"Kinsner","year":"2006","journal-title":"J Neurochem"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/AAC.42.2.277","article-title":"Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin.","volume":"42","author":"Stuertz","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/314760","article-title":"Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis.","volume":"179","author":"Nau","year":"1999","journal-title":"J Infect Dis"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/CCM.0b013e3181a036c0","article-title":"Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.","volume":"37","author":"Spreer","year":"2009","journal-title":"Crit Care Med"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/AAC.47.4.1313-1317.2003","article-title":"Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.","volume":"47","author":"Gerber","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1128\/AAC.47.8.2649-2654.2003","article-title":"Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.","volume":"47","author":"Spreer","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jac\/39.6.781","article-title":"Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.","volume":"39","author":"Nau","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"R11-20230912","first-page":"608","article-title":"CSF interleukin-1 beta, tumor necrosis factor-alpha and free radicals production in relation to clinical outcome in acute bacterial meningitis.","volume":"37","author":"Jain","year":"2000","journal-title":"Indian Pediatr"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2005.06.003","article-title":"TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children.","volume":"34","author":"Mukai","year":"2006","journal-title":"Pediatr Neurol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1442-200X.1994.tb03230.x","article-title":"The fluctuations of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome.","volume":"36","author":"Inoue","year":"1994","journal-title":"Acta Paediatr Jpn"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.PCC.0000102221.98378.7D","article-title":"Cerebrospinal fluid levels of S-100beta in children and its elevation in pediatric meningitis.","volume":"5","author":"Spinella","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/00365540310017294","article-title":"Serum S100B levels in patients with cerebral and extracerebral infectious disease.","volume":"36","author":"Und\u00e9n","year":"2004","journal-title":"Scand J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201706000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:07:10Z","timestamp":1694556430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201706000-00005"}},"subtitle":["A Pilot Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001513","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}